Stock 300436 FUJIAN COSUNTER PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Fujian Cosunter Pharmaceutical Co., Ltd.

Equities

300436

CNE100001YZ0

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 06:00:00 2024-04-29 pm EDT 		5-day change 1st Jan Change
17.94 CNY +2.22% Intraday chart for Fujian Cosunter Pharmaceutical Co., Ltd. +6.28% -30.00%
Apr. 19 Fujian Cosunter Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
2023 Jiangsu Zhongxing Pharm Co., Ltd. cancelled the transaction announced on July 5, 2021 CI

Business Summary

Fujian Cosunter Pharmaceutical Co., Ltd. is a China-based company principally engaged in the research, development, manufacture and sales of nucleoside anti-HBV drugs. The Company's major products include Adefovir Dipivoxil Tablets, Lamivudine Tablets, Entecavir Capsules and other nucleoside anti-HBV drugs. The Company also produces over-the-counter (OTC) drugs, such as ferrous fumarate and ganoderma capsules.

Number of employees: 908

Sales per Business

CNY in Million2022Weight2023Weight Delta
Liver-protecting Drugs
48.0 %
178 46.1 % 203 48.0 % +13.94%
Anti-hepatitis B Virus Drugs
28.8 %
155 40.2 % 122 28.8 % -21.54%
Cardiovascular Drugs
8.4 %
22 5.8 % 36 8.4 % +58.14%
Anti-coronavirus Drugs
5.0 %
- - 21 5.0 % -
Digestive System Drugs
4.5 %
18 4.8 % 19 4.5 % +2.25%
Men's Health Products
2.5 %
3 0.7 % 10 2.5 % +314.68%
Other
2.2 %
6 1.6 % 9 2.2 % +56.44%
Respiratory Drugs
0.7 %
3 0.9 % 3 0.7 % -6.31%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
100.0 %
386 100.0 % 423 100.0 % +9.58%

Managers

Managers TitleAgeSince
Guo Ping Li CEO
 Chief Executive Officer 56 01-06-27
Jian Hui Guan DFI
 Director of Finance/CFO 48 17-07-24
Yuan Li Li CHM
 Chairman 66 10-12-31
Hong Ming Li COO
 Chief Operating Officer 55 21-01-05
Fu hu Huang BRD
 Director/Board Member 48 16-09-19
Guo Dong Li BRD
 Director/Board Member 53 01-12-31
Yang Ding IRC
 Investor Relations Contact 42 -
Qing He Zhang PRN
 Corporate Officer/Principal - 23-05-03

Members of the board

Members of the board TitleAgeSince
Guo Ping Li CEO
 Chief Executive Officer 56 01-06-27
Li Qing Ye BRD
 Director/Board Member 54 11-09-19
Guo Dong Li BRD
 Director/Board Member 53 01-12-31
Yuan Li Li CHM
 Chairman 66 10-12-31
Hong Ren BRD
 Director/Board Member 64 21-01-05
Fu hu Huang BRD
 Director/Board Member 48 16-09-19
Ming Yu Chen BRD
 Director/Board Member 61 17-12-19
Xin Rong Qiang BRD
 Director/Board Member 52 17-12-19
Hai Feng Lin BRD
 Director/Board Member 36 20-07-15
Hong Ming Li COO
 Chief Operating Officer 55 21-01-05

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 159,267,000 80,804,123 ( 50.74 %) 0 50.74 %

Shareholders

NameEquities%Valuation
Guo Ping Li
28.30 %
37,708,868 28.30 % 99 M ¥
Fujian Pingtan Aotai Technology Investment Center LP
6.022 %
8,025,000 6.022 % 21 M ¥
New China Fund Management Co., Ltd.
0.1004 %
133,800 0.1004 % 349 706 ¥
SWS MU Fund Management Co., Ltd.
0.0763 %
101,700 0.0763 % 265 808 ¥
Truvalue Asset Management Co. Ltd.
0.003452 %
4,600 0.003452 % 12 023 ¥
NameEquities%Valuation
Guo Ping Li
30.45 %
7,920,649 30.45 % 21 M ¥
Guo Dong Li
21.63 %
5,625,000 21.63 % 15 M ¥

Company contact information

Fujian Cosunter Pharmaceutical Co., Ltd.

Bldg16, Phase II, Innovation Park No. 7 Wulongjiang Middle Avenue

350108, Fuzhou

+

http://www.cosunter.com
address Fujian Cosunter Pharmaceutical Co., Ltd.(300436)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
FUJIAN COSUNTER PHARMACEUTICAL CO., LTD. Stock Fujian Cosunter Pharmaceutical Co., Ltd.
-30.00% 395M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+26.08% 681B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+21.85% 556B
JOHNSON & JOHNSON Stock Johnson & Johnson
-4.77% 361B
MERCK & CO., INC. Stock Merck & Co., Inc.
+16.97% 325B
ABBVIE INC. Stock AbbVie Inc.
+5.69% 285B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.68% 235B
NOVARTIS AG Stock Novartis AG
+3.65% 199B
ROCHE HOLDING AG Stock Roche Holding AG
-11.12% 189B
PFIZER, INC. Stock Pfizer, Inc.
-3.40% 157B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 300436 Stock
  4. Company Fujian Cosunter Pharmaceutical Co., Ltd.